In the context of obesity and its related maladies, the adipocyte plays a central role in the balance, or imbalance, of metabolic homeostasis. An obese, hypertrophic adipocyte is challenged by many insults including surplus energy, inflammation, insulin resistance, and considerable stress to various organelles. The endoplasmic reticulum (ER) is one such vital organelle that demonstrates significant signs of stress and dysfunction in obesity and insulin resistance. Under normal conditions, the ER must function in the unique and trying environment of the adipocyte, adapting to meet the demands of increased protein synthesis and secretion, energy storage in the form of triglyceride droplet formation, and nutrient sensing, particular to the differentiated fat cell. When nutrients are in pathological excess, the ER is overwhelmed and the unfolded protein response (UPR) is activated. Remarkably, the consequences of UPR activation have been causally linked to the development of insulin resistance through a multitude of possible mechanisms including JNK activation, inflammation, and oxidative stress. This review will focus on the function of the endoplasmic reticulum under normal conditions in the adipocyte, and the pathological effects of a stressed ER contributing to adipocyte dysfunction and a thwarted metabolic homeostasis.
Introduction
The adipocyte and the adipose tissue it populates have begun to fascinate researchers due to rapidly accumulating new knowledge of its function and contribution to whole body metabolic homeostasis. Adipose tissue is highly specialized to store lipid and/or release energy from lipid stores in response to a variety of signals. Adipose tissue also functions as an endocrine organ, secreting specific hormones or adipokines, which act as potent messengers to distant organs such as muscle, liver, and brain, with the purpose of maintaining the body's energy balance and metabolic health.
as JNK and NFκB signaling) are upregulated in obese adipose tissue, leading to increased expression of downstream cytokines such as TNFα, IL-6, and MCP-1, including several others. Many of these pro-inflammatory mediators have been shown to be detrimental to proper insulin signaling, and inhibition of obesity-induced inflammation can improve insulin sensitivity in mice and humans [4] [5] [6] [7] . Indeed, insulin-resistant adipose tissue is burdened with chronic inflammation as well as other possible insults such as hypoxia, oxidative stress, or mechanical stress due to hypertrophy. These insults cumulatively result in organelle dysfunction, particularly in mitochondria and endoplasmic reticulum.
It is hypothesized that a saturated or, perhaps, dysfunctional adipose tissue must send its lipid load elsewhere for storage, thereby causing other organs to become a 'sink' for lipids. This phenomenon, also known as "lipotoxicity", may disrupt the normal function of recipient sites, contributing to pathology in, for example, the liver and muscle tissues as well as pancreatic islets. Thus it follows that adipose dysfunction may be at the center of obesity-related pathologies, and an understanding of its pathology will be crucial to the development of effective preventive and therapeutic strategies. Many genetic models targeting key metabolic pathways in an adipose tissue-restricted manner in mice provided critical proof for this mechanistic concept. For example, loss of Glut4, insulin receptor, or PPARγ in adipocytes resulted in alterations in whole body insulin sensitivity, clearly demonstrating the impact of adipose tissue on systemic energy balance as well as glucose and lipid metabolism [8] [9] [10] .
As stated earlier, various processes have been implicated in the development of the insulin-resistant adipocyte. Inflammation and oxidative stress are two processes shown to be present in obese adipose tissue, and causative for insulin resistance [3, 4, 7] . These processes are highly integrated and likely to work in vicious cycles, reflecting a shortcoming in the adaptive capacity of cells to cope with chronic metabolic surplus. An emerging concept to explain the vast array of maladaptive responses is the presence of organelle dysfunction in obesity, impacting mitochondria and endoplasmic reticulum [11, 12] . Indicative of stress to this latter organelle, the unfolded protein response (UPR) was recently shown to be activated in obese, insulin-resistant tissues in experimental models, and notably, this stress was most prominent in the adipose tissue and contributed to its dysfunction [3, 11] .
In this review we hope to stimulate thinking as regards the impact of endoplasmic reticulum in adipocyte biology, the effects of ER stress upon adipocyte function, and consequently, the implications of adipose tissue stress on whole body metabolic health.
Endoplasmic Reticulum: Regulator of Lipid, Cholesterol, and Protein Metabolism
The endoplasmic reticulum is a specialized cytosolic organelle where various metabolic signals and pathways are integrated to regulate lipid, glucose, cholesterol, and protein metabolism. The ER is a principal site of protein synthesis, and, together with the Golgi apparatus, it facilitates the transport and release of correctly folded proteins. Ribosomes attached to the ER membrane translate de novo peptides into the luminal space. Within the lumen of the ER, protein chaperones such as BiP (GRP78), calnexin, and calreticulin assist in the proper folding of de novo peptides and prevent aggregation of unfolded or misfolded precursors. Once conformationally sound, the proteins are released to the Golgi for final modifications (such as oligosaccharide processing) and transported to their cellular destinations. Cells that are specialized for a high secretory capacity, such as plasma cells, liver cells, and pancreatic beta cells, are known to expand and adopt their endoplasmic reticulum capabilities to meet the increased demand of protein synthesis [13] . As acknowledged in recent years, the adipocyte also acts as a potent endocrine cell, undergoing transformation during differentiation from a fibroblast-like preadipocyte into a mature cell secreting prodigious amounts of peptide and lipid mediators ( Figure 1 ) [14, 15] . Many abundant adipokines, such as leptin, adiponectin, RBP4, and even the fatty acid binding protein ap2, are found at high concentrations in serum [16, 17] . Given the capacity of the adipocyte for protein (and lipid) synthesis and secretion, it follows that the endoplasmic reticulum of a differentiated adipocyte is challenged and may be enhanced to meet the increased demand. In the case of obesity, this expansion may be even more dramatic. Further study in this area is needed to elucidate the role of the ER in adipocyte protein synthesis and secretion.
In addition to protein synthesis, the ER is also the site of triglyceride (TG) droplet formation (The nomenclature also refers to the triglyceride droplet as the lipid body or lipid droplet) [18, 19] . In response to fatty acid accumulation within the cell, triglyceride formation occurs as an energy storage and lipid-neutralizing mechanism. Three fatty acids and one glycerol molecule are joined together to form triglyceride by enzymes resident in the ER membrane, and triglyceride molecules (along with cholesterol) are stored in droplet form; the spherical structure surrounded by a single phospholipid membrane layer and associated proteins. Triglyceride and subsequently, droplet formation, is thought to occur in the endoplasmic reticulum. Indeed, one theory of TG droplet formation states that the droplet originates between the two membranes of the ER, and eventually buds off, carrying the outer cytoplasmic layer of the ER membrane with it, thus explaining the phospholipid monolayer surrounding the spherical structure [9] . In contrast, a second theory has proposed that TG droplet formation occurs outside the ER, but with the ER facilitating synthesis and surrounding the newly formed droplet as an egg is surrounded by an egg cup [20] . Indeed, reports showing organelle spatio-relationships of the adipocyte note the presence of the ER surrounding lipid droplets [21, 22] ( Figure.1) . Regardless of the model, ER membranes are integral components of lipid droplets. Furthermore, multiple studies isolating lipid droplets from cells have shown the presence of the ER chaperone protein BiP on the droplet [23, 24] , supporting its ER origin. Interestingly, the adipocyte, more than any other cell type, is uniquely equipped to store copious amounts of triglyceride and cholesterol in this droplet form, as seen in TG droplet accumulation during differentiation. Release of fatty acids from TG storage by lipolysis also occurs at the TG droplet, and is well correlated with adipocyte size i.e, the larger the cell the higher the rate of lipolysis [25] . It is unknown what role if any the ER plays in the regulation of droplet number, size, or lipolysis; parameters that are all increased in adipocytes. Given the ER origin of the TG droplet and the proximity of the two organelles within the cell, it would be a fascinating idea if the functional interaction and regulation of the TG droplet by the ER persisted after its initial formation.
A third metabolically relevant function of the ER is its role in cholesterol and nutrient by guest, on October 1, 2017 www.jlr.org sensing. Cellular levels of cholesterol are regulated through the SREBP family of transcription factors [26] . The SREBPs, consisting of three isoforms in mammals, SREBP1a,1c and 2, are resident in the ER membrane in an inactive state, retained in precursor form by SCAP proteins (SREBP cleavage activating proteins). In response to low sterol levels (in the case of SREBP1a and 2), or insulin signaling (in the case of SREBP1c), SREBPs are released from binding to the SCAP proteins and translocate to the Golgi where they undergo two successive cleavages resulting in the generation of an activated transcription factor. The activated SREBP then enters the nucleus and acts upon target genes to upregulate cholesterol (SREBP1a and 2), or lipid (SREBP1c) synthesis. SREBP1c expression is induced/required during differentiation in adipocytes and is highly expressed in adipose tissue [27, 28] . SREBP1c is also downregulated in the adipose tissue of obese and insulin-resistant mouse models and human patients [29] [30] [31] .
This shutdown of lipid biosynthesis may possibly be due to the sensing of dietary lipid overload by the hypertrophic (obese) fat cell and may act as a feedback mechanism to maintain homeostasis. One intriguing possibility is that this sensing could occur in the ER. Not only cholesterol but also other nutrients such as amino acids and glucose are 'sensed' by the ER. The nutrient-responsive mTOR pathway upregulates protein synthesis which would naturally increase protein translation and folding in the ER [32] .
Although not proven, it is possible that nutrient overload could engage this pathway and lead to a translational demand overwhelming the ER. In support of this, mTOR activity is increased in obesity [33] , and this augmented signaling may play a role in abnormal insulin action associated with the obese state [34, 35] . Therefore it is possible to conceive that the obesity-related increase in mTOR activity itself may contribute to an ER stress response. Finally, the ER is exquisitely sensitive to glucose availability.
Therefore, nutrient and energy deprivation, or the excess of nutrients, may be perceived by the ER via its stress pathways and lead to the mounting of its adaptive responses commonly referred to as the unfolded protein response (UPR). We now turn to a more detailed description of this important adaptive response.
Stress in the ER: The Unfolded Protein Response
Given the fundamental roles of the ER in integrating multiple metabolic signals and maintaining cellular homeostasis, it is of paramount importance to the cell to maintain proper ER function. Therefore, under conditions of cellular stress leading to an impairment of ER function, proteins are unable to fold properly and accumulate in the ER lumen. It is to these unfolded or misfolded proteins that the ER has evolved a coping system known as the Unfolded Protein Response (UPR) [36] [37] [38] . (Figure 2 In addition to selective inhibition of de novo protein synthesis, the UPR also induces transcription of chaperones to assist with the unfolded protein load. Activated ATF-6 translocates to the nucleus and upregulates gene expression of chaperones such as BiP, calreticulin, and GRP94. The process of ER associated degradation (ERAD) is also upregulated at this time to facilitate clearance and degradation of excess client proteins from the ER lumen. ATF6 induces expression of EDEM (ER degradation-enhancing alpha-mannosidase-like protein), which is involved in this process. ATF-6 also upregulates XBP-1 (X-box protein 1) mRNA which is further processed and specially regulated by the IRE-1 response arm. Bcl-2 family of proteins are thought to play an important role [37, 39] .
ER stress-induced IRE1α phosphorylation leads to the recruitment of TRAF2 (tumor necrosis factor receptor-associated factor 2) and ASK1 (apoptosis signal-regulating kinase 1) to the cytosolic leaflet of the ER membrane [40, 41] . This complex of three proteins phosphorylates and consequently activates JNK. JNK activity may lead to a variety of downstream effects depending on the cellular context, some of which include: apoptosis, cell survival, inflammation, and insulin resistance. For the purpose of this discussion, we will focus on the actions of JNK in regulating metabolism, primarily through the processes of inflammation and insulin receptor signaling. Obesity leads to marked activation of JNK in metabolically active tissues, such as liver, muscle, and adipose tissues [42] . JNK activity is also detrimental for pancreatic islet function and survival [43] . In the cytoplasm, JNK1 acts to inhibit insulin signaling through phosphorylation of the Insulin Receptor Substrate 1 (IRS-1) on serine 307 [44] . JNKmediated serine phosphorylation of IRS-1 inhibits insulin receptor signaling through several mechanisms, including the loss of its ability to serve as a substrate, disruption of Insulin Receptor-IRS-1 interaction, and when the stress is severe and prolonged, IRS-1 degradation. Indeed, mice with a genetic deficiency of JNK1 display marked protection from diet-induced obesity and insulin resistance [42] .
In the nucleus, JNK phosphorylates the transcription factor PPARγ, a major regulator of glucose and lipid homeostasis in the adipocyte and major effector of insulin sensitivity in the human and mouse [45, 46] . This phosphorylation may inhibit PPARγ activity and negatively affect insulin sensitivity in the cell. However, further study is needed to elucidate this interaction and its functional consequences in vivo.
The UPR and the Inflammatory Response
ER Stress and the UPR are linked to major inflammatory and stress signaling networks via several distinct mechanisms, including the activation of JNK-AP-1 and IKK-NF-κB pathways, as well as production of reactive oxygen species (ROS). Interestingly, these are also the pathways and mechanisms which play a central role in obesity-induced inflammation and metabolic abnormalities. For example, JNK activation by IRE-1α during ER stress is one key pathway to increased inflammation. In the nucleus, JNK upregulates the expression of inflammatory genes through activation of the AP-1 transcription factor complexes [47] . Indeed, the beneficial metabolic effects observed in the JNK1-deficient mouse may be mediated, at least in part, through suppression of inflammatory cytokines, as JNK deficient animals display decreased levels of TNFα, IL-6, and MCP-1 (among others) compared to wild type mice on a high fat diet [48] . IRE-1α can also activate the IKK-NFκB pathway, which is critical in the induction of multiple inflammatory genes such as TNFα and IL-6, and is also implicated in insulin resistance [7, 49, 50] . The NFκB pathway may also be activated through PERK signaling during the UPR. PERK-mediated phosphorylation of eIF2α results in inhibition of translation of the IκB protein, the major negative regulator of NFκB, thus allowing activation of NFκB and induction of its pro-inflammatory targets [50] [51] [52] . In vitro, induction of the UPR in various cell types has been reported to cause increased expression of inflammatory genes, including IL-8, IL-6, MCP-1, and TNFα [53, 54] .
UPR-mediated upregulation of acute phase response genes through an ER-resident transcription factor in liver has also been reported [55] . Prolonged activation of the UPR may also generate oxidative stress, causing a toxic accumulation of ROS within the cell.
This occurs due to UPR-stimulated upregulation of chaperone proteins involved in disulfide bond formation in the ER lumen. The enzymes responsible for forming disulfide bonds (Ero1p and Erv2p) use oxidation-reduction reactions which utilize molecular oxygen as the final electron recipient [56] . This reduced molecular oxygen accumulates during UPR-increased protein folding and acts as a cellular toxic ROS [57] .
The UPR has even evolved to anticipate this increase in ROS, as one of the three branches (PERK) activates an antioxidant program through the transcription factor Nrf2, keeping toxic species under control. In addition, it is well appreciated that toxic ROS levels may also elicit an inflammatory response, thus drawing yet another connection between UPR activation and inflammation.
The close link between ER stress and inflammation is important given the role of inflammation in obesity and insulin resistance [3] . As described earlier, obese adipose tissue is characterized by a chronic, elevated inflammatory response, and various inflammatory pathways have been implicated in the development of insulin resistance.
Finally, adipocyte death may be a contributor to the inflammation in obese adipose tissue [58] , and ER stress may play a role in this death via its ability to engage apoptotic by guest, on October 1, 2017
www.jlr.org pathways. Therefore, whether through direct activation of inflammatory pathways, or indirectly through adipocyte death, the intriguing possibility remains that ER stress is a cause of obesity-induced inflammation. Studies are underway to address this possibility.
ER stress in the Adipocyte
Given the evidence that the UPR is a source of stress signaling, inflammation, and JNK activation and the fact that these two events are strongly linked to inhibition of insulin signaling, we hypothesized that one cause of insulin resistance in the obese state is the presence of ER stress within the expanded adipose tissue. Indeed, in adipose tissue of mice fed a high fat diet for 16 weeks, indicators of ER stress such as PERK phosphorylation and JNK activity are significantly increased compared to mice fed a regular diet [11] . In ob/ob mice, which become severely obese due to a mutation in the leptin gene, adipose tissue displays signs of ER stress including increased levels of phosphorylated PERK and IRE-1α when compared to wild-type mice. These markers of UPR activation in ob/ob adipose tissue were also accompanied by an increase in JNK activity and XBP-1 splicing [11, 59] . Genetically, ER stress may be caused by insufficiency of the XBP-1 transcription factor [11] . As homozygote XBP-1 null mice are not viable, XBP-1 heterozygous mice were investigated for the effects of ER stress on metabolic homeostasis [11] . Remarkably, on a high-fat diet, XBP-1 +/-mice developed hyperinsulinemia, hyperglycemia, and impaired glucose and insulin tolerance compared to wild-type controls. Body weight increased in XBP-1 +/-mice compared to wild-type, and notably, the adipose tissue of XBP +/-mice displayed increased phosphorylation of PERK and IRE-1α, and also increased JNK activity, coupled with a loss of insulin sensitivity.
In complement, recent studies described the function of the ER chaperone protein ORP150 (Oxygen Regulated Protein 150) in mouse metabolic homeostasis [60, 61] .
ORP150 is induced by the UPR, and plays a protective role during ER stress. Loss of ORP150 expression in either whole body or liver alone resulted in impaired glucose tolerance and decreased insulin-stimulated signaling through IRS- [63] . Interestingly, the UPR-induced transcription factors ATF4 and CHOP were shown to upregulate Trb3 mRNA through binding to its promoter [64, 65] . Buse and colleagues then demonstrated that UPR activation by glucose deprivation or tunicamycin treatment in 3T3 L1 adipocytes induced CHOP and, subsequently, Trb3 mRNA [66] . It may be the case that in adipocytes, a UPR-induced Trb3 could reduce Akt activation and subsequently affect adipocyte function offering an additional pathway connecting UPR activation and insulin resistance. A second interesting lead may come from a study investigating the effects of HIV protease inhibitors on 3T3 L1 adipocytes and HepG2 liver cells [67] . Using microarray comparisons, the authors showed that the protease inhibitors induced ER stress genes in both cell types. Coupled with this, lipogenic genes were down-regulated in the adipocyte but upregulated in the hepatocyte. This is a noteworthy observation given its similarity to the in vivo obese, type 2 diabetic state, where lipogenesis is decreased in the adipose tissue but increased in the liver, with both tissues displaying ER stress [67] . Along these lines, another study using HIV proteasome inhibitors in 3T3-F442A adipocytes reported decreased nuclear-translocation of SREBP1c upon exposure to these drugs [68] . Given that SREBP1c increases lipogenic gene expression, this result may be indicative of dysfunction in the ER leading to decreased lipid synthesis.
As of yet, there are many unexplored areas of adipocyte function in regards to ER stress. known condition of UPR activation in many cell types, including adipocytes [66] .
Glucose deprivation may occur in obese adipocytes due to cellular insulin resistance.
Once insulin signaling has been inhibited, glucose uptake is reduced, and the cell may be stressed due to low-glucose conditions or abnormal fluxes. Second, the tissue environment may be glucose or nutrient deprived. Studies in the rat have shown decreased vasculature of adipose tissue in obese versus lean condition [75] . This "starvation" of the adipose in the face of plenty may be sufficient to induce stress.
Support for this concept comes from recent work by Hosogai et al., indicating that obese mouse adipose tissue shows signs of hypoxia compared to wild type tissue. In cultured adipocytes, hypoxia induces the UPR, as evidenced by BiP and CHOP mRNA induction, eIF2α phosphorylation, and XBP-1 splicing [76] .
ER stress may also be caused by the inflammatory state of obese adipose tissue. As described previously, the UPR is able to induce inflammatory gene expression in a variety of cell types. Remarkably, the converse may also be true-that inflammation induces the UPR. Indeed, TNFα was shown to activate the UPR in mouse fibrosarcoma cells [77] . The mechanism of TNFα -UPR induction was shown to be dependent upon ROS. Therefore, oxidative stress is yet another possibility for the cause of obesityrelated ER stress, as various studies have shown that ROS is able to activate the UPR [77, 78] . This is relevant given recent evidence that describes an increase in oxidative stress markers in the adipose tissue of obese/insulin resistant mice and humans [79] , and in cultured adipocytes ROS have been shown to cause insulin resistance [80] . As many of these stress signals converge on common pathways and can regulate each other it is likely that their coordinates regulation is a feature of obesity and likely the cause for feedback regulation and perpetuation of the inflammation.
Therapeutic Potential for the Adipocyte ER
The cause-effect cycles in obesity with respect to stress and inflammation are complex.
Vicious forward loops may occur because the causes of ER stress (ie. ROS or inflammation) are also the consequences. Therefore increased oxidative stress or inflammation will result in its own amplification, as it attacks various organelles and signaling pathways in the cell. (Figure 3 ) Given this complexity, one approach to therapy may be to focus on whole organelles as sources of multiple stressors, the relief of which may have multiple beneficial effects. Maintenance or enhancement of proper ER function may be one such method of organelle therapy. It has been demonstrated that ER folding is enhanced with the treatment of small molecules classified under the category of chemical chaperones [81] . Although the mechanism(s) of action for chemical chaperones is unclear, they are classified as such for their ability to protect the cell from ER stress [82] , and to facilitate protein folding and export. Two of these molecules, 4-phenyl butyric acid (PBA) and taurine-conjugated ursodeoxycholic acid (TUDCA), were recently tested in our laboratory in a mouse model of obesity [59] . In obese and insulin resistant ob/ob mice, treatment with either PBA or TUDCA dramatically improved glucose tolerance, lowered blood glucose and insulin levels, and increased systemic insulin sensitivity, without significantly affecting body weight. When liver and adipose tissues were investigated for UPR activation, tissues from chaperone-treated mice Further support for the beneficial effects of enriching ER function comes from the study of the ORP150 transgenic mouse [61] . Diabetic mice overexpressing the ER chaperone ORP150 displayed improved glucose tolerance when compared to non-transgenic diabetic mice. Insulin signaling in liver and muscle was also enhanced in the transgenic mouse. Another way to reduce ER stress may be through direct targeting of UPRinvolved molecules. For example, the small molecule drug Salubrinal was recently shown to inhibit dephosphorylation of eIF2α, leading to a sustained repression of protein synthesis and rescue from ER stress [83] . Indeed, Salubrinal protected cells from ER stress-induced cell death via agents such as tunicamycin and brefeldin A. In one model of neuronal toxicity (due to increased glutamate receptor activation), Salubrinal treatment protected against ER stress and cell death in vitro and importantly, in vivo in the rat [84] .
However, given that the effects of Salubrinal may vary according to tissue [85] , testing in animal models of ER stress diseases remains an important future step. Intriguingly, two chemicals in use or in clinical trials for the treatment of type 2 diabetes have also been
shown to have effects on eIF2α. Thiazolidinediones, known agonists of PPARγ, were
shown to phosphorylate eIF2α and inhibit protein synthesis independent of PPARγ [86] .
Secondly, the anti-inflammatory salicylates also lead to increased eIF2α phosphorylation via PERK activation [87] . It is exciting to speculate that the beneficial effects of these therapies may be related to their ability to protect/maintain ER function through UPR To conclude, the adipocyte, and thus adipose tissue, has been and will continue to be central to the study of obesity and its related pathologies. It is imperative to understand the alterations that occur from the life of a healthy adipocyte to a hypertrophic insulinresistant adipocyte (Figure 3) , to perhaps even a dead adipocyte. A deepening knowledge of adipose tissue expansion and the dysfunction that follows will be critical to our thinking and therapy in the coming years. by guest, on October 1, 2017
